SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 148 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $241,000 | -39.1% | 83,000 | -6.7% | 0.29% | -36.1% |
Q2 2017 | $396,000 | -4.6% | 89,000 | 0.0% | 0.46% | +1.3% |
Q1 2017 | $415,000 | -23.4% | 89,000 | 0.0% | 0.45% | -21.5% |
Q4 2016 | $542,000 | +14.6% | 89,000 | 0.0% | 0.58% | +29.0% |
Q3 2016 | $473,000 | +39.9% | 89,000 | 0.0% | 0.45% | +41.3% |
Q2 2016 | $338,000 | +37.4% | 89,000 | 0.0% | 0.32% | +40.9% |
Q1 2016 | $246,000 | -32.2% | 89,000 | +39.1% | 0.22% | -20.8% |
Q4 2015 | $363,000 | +7.1% | 64,000 | 0.0% | 0.28% | +4.4% |
Q3 2015 | $339,000 | -38.9% | 64,000 | -4.3% | 0.27% | -28.0% |
Q2 2015 | $555,000 | +79.6% | 66,900 | 0.0% | 0.38% | +64.3% |
Q1 2015 | $309,000 | +103.3% | 66,900 | +33.8% | 0.23% | +180.5% |
Q4 2014 | $152,000 | – | 50,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 7,590,000 | $28,842,000 | 8.26% |
Asymmetry Capital Management, L.P. | 298,190 | $1,133,000 | 2.08% |
ARMISTICE CAPITAL, LLC | 1,330,000 | $5,054,000 | 1.92% |
Belmont Global Advisors, Inc. | 385,000 | $1,463,000 | 1.40% |
Paulson & Co. | 27,756,668 | $105,475,000 | 1.07% |
Trellus Management Company, LLC | 162,900 | $619,000 | 1.01% |
DAFNA Capital Management LLC | 319,563 | $1,214,000 | 0.96% |
PURA VIDA INVESTMENTS, LLC | 350,000 | $1,330,000 | 0.56% |
WALL STREET ASSOCIATES | 269,300 | $1,023,000 | 0.41% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,603,334 | $6,093,000 | 0.34% |